Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Pioglitazone, Metformin and the Combination of Both on Cardiovascular Risk in Insulin-treated Patients With Type 2 Diabetes - The PIOcomb Study

NCT00770445 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00770445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Pioglitazone, Metformin and the Combination of Both on Cardiovascular Risk in Insulin-treated Patients With Type 2 Diabetes - The PIOcomb Study
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2008
Completion date
July 31, 2010
Enrollment
121 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus